Medeze Group PCL (BKK:MEDEZE)

Thailand flag Thailand · Delayed Price · Currency is THB
6.30
-0.10 (-1.56%)
At close: Mar 6, 2026
-24.55%
Market Cap 6.73B
Revenue (ttm) 776.41M
Net Income (ttm) 196.38M
Shares Out 1.07B
EPS (ttm) 0.18
PE Ratio 34.26
Forward PE 20.00
Dividend 0.16 (2.50%)
Ex-Dividend Date Apr 29, 2026
Volume 435,543
Average Volume 1,467,957
Open 6.35
Previous Close 6.40
Day's Range 6.30 - 6.40
52-Week Range 5.75 - 8.65
Beta n/a
RSI 42.36
Earnings Date Mar 2, 2026

About Medeze Group PCL

Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, Philippines, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells. In addition, the company is involved in research, develops, and collects data on all types of human cellular act... [Read more]

Sector Healthcare
Founded 2010
Employees 200
Stock Exchange Stock Exchange of Thailand
Ticker Symbol MEDEZE
Full Company Profile

Financial Performance

In 2025, Medeze Group PCL's revenue was 776.41 million, a decrease of -11.15% compared to the previous year's 873.87 million. Earnings were 196.38 million, a decrease of -42.03%.

Financial Statements

News

There is no news available yet.